- Published at
- by manilatimes.net
mixed
mixed
News for Telix Pharmaceuticals Limited (TLPPF)
- Published at
- by benzinga.com
positivepositiveThis Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Excelerate Energy (NYSE:EE), Atossa Therapeutics (NASDAQ:ATOS)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...- Published at
- by manilatimes.net
positivepositiveTelix Manufacturing Solutions (TMS) Established in Yokohama, Japan
MELBOURNE, Australia and KYOTO, Japan, June 4, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix', 'the Company') today announces that it has established Telix Manufacturing Solutions (TMS) in Yokohama, Japan. Telix's first cyclotron facility in the Asia Pacific region represents a significant milestone in the Company's global manufacturing strategy.- Published at
- by gurufocus.com
positivepositiveTelix Investor Day in New York City on June 11, 2025: Presenting KOLs
MELBOURNE, Australia and INDIANAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, TLX, ”Telix”, ”the Company”) provid- Published at
- by gurufocus.com
positivepositiveTelix to Host Investor Day in New York City on June 11, 2025
MELBOURNE, Australia and INDIANAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, TLX, ”Telix”, ”the Company”) today a- Published at
- by manilatimes.net
mixedmixedTelix at ANZSNM Annual Scientific Meeting 2025
MELBOURNE, Australia, May 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix', 'the Company') today announces a strong presence at the 55th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM ASM 2025), to be held in Melbourne, Australia from 23-25 May 2025.- Published at
- by insidermonkey.com
positivepositive11 Best Australian Stocks to Buy According to Analysts
The tariffs announced by the United States have challenged the economic and market outlooks around the globe.- Published at
- by manilatimes.net
positivepositiveTelix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
MELBOURNE, Australia and INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been published in Thyroid, the official journal of the American Thyroid Association. The candidate demonstrated an encouraging safety profile and efficacy in aggressive, radioiodine-resistant (RAI-R) thyroid cancer[1].- Published at
- by gurufocus.com
positivepositiveTelix's Illuccix PSMA-PET Imaging Agent Approved in France
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- T- Published at
- by gurufocus.com
positivepositiveTelix Pharmaceuticals (TLX) Reports Strong Q1 2025 Performance
Telix Pharmaceuticals experiences substantial revenue growth in Q1 2025. Prostate imaging products, Illuccix and Gozellix, are key drivers of success.- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
positivepositiveIPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, TLX, Telix, the Company) today announces p- Published at
- by manilatimes.net
positivepositive- Published at
- by zacks.com
neutralneutralAll You Need to Know About Telix Pharmaceuticals Limited (TLX) Rating Upgrade to Buy
Telix Pharmaceuticals Limited (TLX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
positivepositiveTelix Appoints Paul Schaffer as Chief Technology Officer
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, TLX, Telix, the Company) today announces t- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositiveTelix Appoints Paul Schaffer as Chief Technology Officer
MELBOURNE, Australia and INDIANAPOLIS, April 7, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology Officer (CTO), effective today.- Published at
- by gurufocus.com
positivepositiveAnne Whitaker Appointed as Non-Executive Director
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, TLX, Telix, the Company) today announces t- Published at
- by manilatimes.net
mixedmixed